Jinze Li
- Urology top 5%
- Urinary Bladder and Prostate Research 11
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 7
- Inflammatory Biomarkers in Disease Prognosis 6
-
- Prostate Cancer Diagnosis and Treatment 11
- Ferroptosis and cancer prognosis 7
- Renal cell carcinoma treatment 5
-
- Bladder and Urothelial Cancer Treatments 13
- Urinary and Genital Oncology Studies 7
- Journals
- Journal of Clinical Oncology (1 paper)Cancer Research (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jinze Li
71 papers receiving 929 citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Urology 102
- Oncology 251
- Pulmonary and Respiratory Medicine 212
- Cancer Research 91
- Endocrinology, Diabetes and Metabolism 92
Countries citing papers authored by Jinze Li
This map shows the geographic impact of Jinze Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinze Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinze Li more than expected).
Fields of papers citing papers by Jinze Li
This network shows the impact of papers produced by Jinze Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinze Li. The network helps show where Jinze Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jinze Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 24 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 7 | |
| 11 | 2024 | 2 | |
| 12 | 2023 | 14 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 63 | |
| 15 | 2023 | 0 | |
| 16 | 2022 | 1 | |
| 17 | 2022 | 5 | |
| 18 | 2022 | 5 | |
| 19 | 2022 | 13 | |
| 20 | 2020 | 2 |
About Jinze Li
Jinze Li is a scholar working on Urology, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 83 papers that have together received 952 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (13 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Urinary Bladder and Prostate Research (11 papers), Cancer Immunotherapy and Biomarkers (7 papers), Urinary and Genital Oncology Studies (7 papers), Ferroptosis and cancer prognosis (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Urology (102 citations), Oncology (251 citations) and Pulmonary and Respiratory Medicine (212 citations). Jinze Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Dehong Cao, Qiang Wei, Jack Uetrecht, Yin Huang, Liangren Liu, Lei Peng, Yunxiang Li, Zeyu Chen, Puze Wang and Ruyi Wang. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.